The healthcare investment management firm is working with the city's nonprofit economic development corporation and Chicago-based MATTER on the new project, which will focus on life sciences and digital health.
Under the deal, which awaits city council approval, illustrates Seattle's rapid growth as a life sciences hub, in addition to its larger IT sector. The nearly 3-acre parcel sits in a rapidly growing neighborhood that is also home to Amazon.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
While it trails its U.S. counterpart, Europe's life science sector has seen an increase in interest from investors lately. A report released Thursday by Silicon Valley Bank indicates growing investment in European biopharma and diagnostics.
Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.
The report, by law firm WSGR, noted an almost twofold increase in life sciences IPOs - especially biotech - and a greater number priced at $250 million or more.
A number of scenarios could indeed diminish the UK's attractiveness, but it is likely to remain an important player, with a lot riding on the future regulatory regime.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Deals worth $50 million or more are becoming more frequent, even in Series A. But a VC investor said underlying drivers in life sciences are different from the technology sector.
With $320 million on hand to invest in life sciences startups, Westlake Village BioPartners will tap its founders' biotechnology expertise.
The company's life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.
McDermott Will & Emery partner Kristian Werling is co-chair of the firm’s robust Life Sciences practice. According to Krist, McDermott’s Life Sciences group has “all the tools in the toolkit to help life science entrepreneurs, growth-stage companies and large global companies achieve their patient-centered mission. Hearing patients, helping heal patients and everything in between.” About […]
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
These transactions best exemplify the most significant trends in the life sciences and biotech space.
One year ago, in collaboration with Lake Whillans and our sister site MedCity News, we launched the inaugural Life Sciences Law Firm Index to recognize law firms that are the most active and relevant for life science companies. Over the course of 2016, we have published updates to the Index, each focusing on a different practice area. Today, […]
We live in a golden age of medicine. Never before have so many effective treatment options been available to so many people. And precision medicine is bringing new horizons, as well as the promise to further improve disease prevention, treatment, and ultimately find more cures. To keep moving toward personalized medicine approaches, more individuals would […]
This week we will take a closer look at how players like Alphabet (Google in general) are really making an impact in healthcare innovation. Does it look promising?
Cimphoni is expanding its reach with the addition of its Life Sciences division, which is focusing on treatment of osteoporosis, accelerated fracture healing and the diagnosis of periprosthetic joint infections.